Synthesis of lysophosphatidylserine with 19:4 acyl group, as a novel sodium-potassium atpase inhibitor, in relation to dlis-2, an endogenous digoxin-like substance
Synthesis of lysophosphatidylserine with 19:4 acyl group, as a novel sodium-potassium atpase inhibitor, in relation to dlis-2, an endogenous digoxin-like substance